U.S. market Open. Closes in 6 hours 12 minutes

XBIOW | Xenetic Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-11-302013-08-312012-11-302012-08-31
Revenue2.54M1.71M1.16M436.94K17.07KN/A7.58M3.00MN/AN/A1.00M96.90K293.60K112.79K
Cost of RevenueN/A27.04K35.48KN/AN/AN/A156.12KN/AN/AN/AN/AN/A44.84KN/A
Gross Profit2.54M1.68M1.13M436.94K17.07KN/A7.43M3.00MN/AN/A1.00M96.90K248.76K112.79K
Operating Expenses7.06M8.42M6.91M5.13M9.62M7.28M11.00M50.43M9.82M12.92M9.61M162.46K5.51M229.45K
Selling, General & Admin3.56M3.65M3.74M3.40M4.73M4.39M6.94M6.69M6.39M6.60M6.55M114.03K3.56M173.78K
Research & Development3.49M4.77M3.16M1.73M4.89M2.88M4.06M43.74M3.43M6.32M3.06MN/A1.94MN/A
Other Operating Expenses25.38K-1.60K1.12K-492.003.31K-24.64K-41.10KN/AN/AN/AN/A48.42KN/A55.67K
Operating Income-4.52M-6.72M-5.75M4.55M-12.89M-7.28M-3.57M-47.43M-9.82M-12.92M-8.61M-65.56K-5.26M-116.66K
Other Expenses / Income381.14K165.56K101.59K-18.36M111.80K-24.64K-41.10K-6.78M-2.69M-1.38M34.22K-23.61K-1.07M-13.01K
Before Tax Income-4.13M-6.55M-5.65M-13.81M-12.78M-7.30M-3.60M-54.21M-12.51M-14.31M-8.58M-89.17K-6.33M-129.67K
Income Tax Expenses28.21K-165.56K-100.47K-2.92M3.17M24.13KN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-4.13M-6.39M-5.54M-10.89M-15.95M-7.30M-3.60M-54.21M-12.51M-14.31M-8.58M-89.17K-6.33M-129.67K
Interest ExpensesN/A-165.56KN/AN/AN/A24.13K1.82K729.57K267.00K4.71K632.0012.95K51.74K13.01K
Basic Shares Outstanding1.53M1.42M1.03M639.24K285.25K75.60KN/A7.43M140.40M135.90M135.90M135.90M135.90M135.90M
Diluted Shares Outstanding1.53M1.42M1.03M639.24K285.25K75.60KN/A7.43M140.40M135.90M135.90M135.90M135.90M135.90M
EBITDA-4.52M-6.69M-5.71M4.58M-6.29M-7.26M-3.57M-52.90M-9.66M-12.84M-8.53M-37.68K-6.17M-97.18K
EBITDA Margin-177.79%-391.98%-492.06%1,047.61%-36,872.05%0.00%-47.06%-1,763.19%0.00%0.00%-852.66%-38.89%-2,102.15%-86.16%
EBIT-4.11M-6.72M-5.65M-13.81M-12.78M-7.25M-3.59M-53.48M-12.24M-14.30M-8.58M-76.22K-6.28M-116.66K
EBIT Margin-161.67%-393.57%-486.36%-3,161.06%-74,856.59%0.00%-47.37%-1,782.55%0.00%0.00%-857.86%-78.66%-2,137.79%-103.44%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-11-302013-08-312012-11-302012-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙